by | Dec 30, 2022 | Uncategorized
Beijing’s decision to approve the drug, its second developed abroad after Pfizer’s Paxlovid, comes amid domestic shortages of everything from fever-reducing medicines to antivirals that prevents severe disease. Read More
by | Dec 30, 2022 | Uncategorized
The Bahamian Securities Commission said it took control of the assets on Nov. 12, citing a risk of “imminent dissipation.” Read More
by | Dec 30, 2022 | Uncategorized
It’s still possible for big companies—but also individual crypto owners—to take advantage of special tax treatment for Bitcoin and other digital assets. Read More
by | Dec 30, 2022 | Uncategorized
The spending bill will keep the government operating through to September 2023. Read More
by | Dec 29, 2022 | Uncategorized
The FDA approved Biogen’s Alzheimer’s drug last year even as a panel of outside medical experts expressed concerns about its efficacy. Read More
Recent Comments